Decoded

What if AI's biggest threat is not a smarter machine, but a less curious human?

In this episode of Decoded, Dr. Jurgi Camblong sits down with Pr. Joseph Sifakis, Turing Award laureate and inventor of model checking, the mathematical method that taught machines to prove their own correctness. Joseph has spent fifty years building the foundations of systems we can trust.

Now he is asking whether we are ready to trust them with our minds.

You'll hear:
•Why current AI cannot reason and what real autonomy would actually require
•Does the difference between symbolic and connectionist AI actually matter?
•Why being correct is not enough: systems also need values and accountability
•Why human cognitive dependence, not superintelligence, is the risk that worries him most
•What he tells young people about living a life worth living
A rigorous, clear-eyed, and unexpectedly hopeful conversation about intelligence; human and artificial.
For more information on this episode follow the link below:
https://www.linkedin.com/in/jurgicamblong/ 
https://www.sophiagenetics.com/podcasts/

What if healthcare systems aren't broken — they're just built for the wrong job?
In this episode of Decoded, Dr. Jurgi Camblong sits down with Lord David Prior, who spent years running the NHS from the inside, to explore why shifting from sick care to health care — powered by AI and data-driven medicine — may be healthcare's next real leap forward.
From investment banking to restructuring British Steel to leading the NHS, David has spent his career inside institutions at moments of change. Few people remain this optimistic about what comes next.
You'll hear:
Why treating illness late is the wrong model
How data-driven medicine could widen access to good care
What's really standing between genomics and everyday care
Why David compares healthcare today to Henry Ford's Model T
A candid, optimistic conversation about building healthcare for the world we actually live in.
For more information on this episode follow the link below:
https://www.linkedin.com/in/jurgicamblong/ 
https://www.sophiagenetics.com/podcasts/

What does it take to ask one question — *how do you free software from hardware?* — and end up reshaping the entire computing industry? In this episode of Decoded, Dr. Jurgi Camblong speaks with Edouard Bugnion, co-founder of VMware and Vice President for Innovation and Impact at EPFL, the Swiss Federal Institute of Technology in Lausanne. VMware didn't just build a product. It built the foundation on which the modern cloud was built — and was acquired by Broadcom in 2023 for $69 billion. From a childhood in Neuchâtel to a PhD at Stanford, from research lab to billion-dollar company, and back to Switzerland as a professor and public advisor, Edouard has spent his career at the precise intersection of deep science and real-world impact. You'll hear how a single idea about separating software from hardware gave birth to an industry, what the dot-com crash taught him about building through uncertainty, the three factors he believes determine whether a company succeeds or fails, why the energy cost of AI is a problem that can't be wished away, and what it actually means to be responsible when innovation moves faster than society can keep up. This episode is about what happens when a scientist becomes a builder, and why the most important question in technology right now may not be *what can AI do* — but *what should it do.*

What does it take to turn a two-person startup in Paris into a $6.8 billion exit, and then do it all over again for 200 other founders?

In this episode of Decoded, Dr. Jurgi Camblong speaks with Bernard Liautaud, co-founder of BusinessObjects and Managing Partner at Balderton Capital, one of Europe's leading venture capital firms backing category-defining companies like Revolut, Wayve, and Quantum Systems.
Bernard didn't just build a company. He built a category. Starting with two people in Paris in 1990, he helped define what business intelligence could be, took the company to NASDAQ, and sold it to SAP for $6.8 billion. Then he turned that experience into fuel for the next generation of European founders.
You'll hear why Europe's VC returns have quietly outperformed the US, how Balderton evaluates founders and the one trait they call "insurgency," what the story of Revolut reveals about the power of execution, why Bernard believes Europe has not just the talent but the values to build AI responsibly, and the philosophy behind his most personal insight: as a VC, you have many shots. As a founder, you have one.
This episode is about what happens when ambition meets experience, and why Europe's most exciting chapter may still be ahead of us.

What happens when a world-class biologist decides that academic research isn't moving fast enough for patients? 

Dr. Keith Flaherty is a physician, scientist, and founder who obsesses over the "wiring of cells". As the Director of Clinical Research at the Mass General Hospital Cancer Center and a Professor of Medicine at Harvard Medical School, he has authored over 300 peer-reviewed research publications. But he didn't stop at academia. He went on to co-found Loxo Oncology and Scorpion Therapeutics, driving billions in acquisitions and fundamentally changing precision cancer care. 

In this episode, Keith joins Dr. Jurgi Camblong to discuss his journey from early cell biology to becoming president of the AACR. They explore the evolution of melanoma treatments, the mechanics of targeted inhibitors, and the friction in the system that prevents us from learning from every patient. 

Because better outcomes don’t come from better science alone. They come from making the whole system work. 

#Oncology #PrecisionMedicine #AACR #DrugDevelopment #DecodedPodcast